Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
about
Novel allelic variants in the canine cyclooxgenase-2 (Cox-2) promoter are associated with renal dysplasia in dogsInteraction of cyclooxygenases with an apoptosis- and autoimmunity-associated proteinCardiomyocyte cyclooxygenase-2 influences cardiac rhythm and functionMixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanesImpaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthasePhysiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyNucleobindin co-localizes and associates with cyclooxygenase (COX)-2 in human neutrophilsWhy there are two cyclooxygenase isozymes.Is COX-2 inhibition a panacea for cancer prevention?Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioningDose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibitionInduction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathwayPhysiology of kidney reninThe prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressureAlterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinomaEffects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challengeCyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in miceNon-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferationThe growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1Nonsteroidal Anti-Inflammatory Drugs and the KidneyOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin IIIncreased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medullaTemporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the ratKey enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse)CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodentsPostnatal regulation of 15-hydroxyprostaglandin dehydrogenase in the rat kidneyProstaglandin signaling regulates nephron segment patterning of renal progenitors during zebrafish kidney developmentEfficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi SarcomaDiscovering chemical modifiers of oncogene-regulated hematopoietic differentiationInteractions between NO, CO and an endothelium-derived hyperpolarizing factor (EDHF) in maintaining patency of the ductus arteriosus in the mouse.Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse modelsIbuprofen slows migration and inhibits bowel colonization by enteric nervous system precursors in zebrafish, chick and mouse.YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2.Altered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model.Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.Cyclooxygenase-dependent signalling: molecular events and consequences.Restoration of on-time embryo implantation corrects the timing of parturition in cytosolic phospholipase A2 group IVA deficient miceUCP1 induction during recruitment of brown adipocytes in white adipose tissue is dependent on cyclooxygenase activity.COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.
P2860
Q21089983-E446A552-2A95-44C1-A5BA-D1272A92ECACQ24604296-482A9B0B-CE10-4663-85F2-C61702C076ABQ24657715-F387424F-A769-42BB-89E3-5D77282685C3Q24671911-1D32A3A6-9BCB-4578-B6EE-D6B80E83EB6AQ24678462-1D4FEC7E-125E-4514-AC7B-FD692129096BQ26771378-E0408A0C-02A5-4BA8-B6EE-388EEDEC8C6DQ27301317-EC9CA234-E014-41FD-9571-3AE0B83CB75BQ27863307-8390B400-C0EB-464A-AE4A-F455D78E2950Q28191891-140DFAAE-CAFA-4B1B-9C05-58AE3DE1DF0BQ28193545-483BD73A-A658-48D9-95C2-C661793EBF6BQ28213226-7CD06B12-0454-41A8-8121-B0B97381EA40Q28270455-F5272EB1-EB7E-44BC-AA90-A36637A1DF06Q28279771-BB3A4F1D-CCA1-44EC-A0EE-96FA00770CD6Q28346548-994E947C-A2BF-4563-B486-2FED8D72E1AAQ28360358-D1E318FD-A61E-4B82-9CD4-E8E4F3AF8264Q28361239-D8DB8075-DA7C-4D2B-A991-1F195425525CQ28362073-0A9FF2FC-E785-4477-9A89-43E8C12E07D3Q28362626-32D879E2-D8CB-4653-8D5D-A9DEFF6A84D7Q28363021-CE37CED1-45D7-4DA5-8473-5C3483E7F374Q28386844-ACB00B13-4DB2-4961-A502-1E3E3E35D2D4Q28508911-9635D6CF-D813-4488-99FD-F6D964FC93B8Q28577490-83E879CD-8BE8-4F0C-9AD0-CB628DB13FCDQ28582867-A81F2CC6-AFA0-4B40-84F4-53E7730B3DF4Q28583685-BA6256BE-A5A6-40DB-AB40-0B208C5E9D39Q28755557-887359F6-B468-4EFB-98A0-3909D6BCD94AQ28771395-62A13D4A-9EFD-4D0A-B0B6-DEF738468CF9Q28816964-AED8CF52-B105-4288-A7C3-0618A8939EBAQ28817969-16C8A016-B988-43C6-80F1-4E6CAF92EA1FQ30438385-57DD20B9-7D5C-4368-B494-6FAE8E868158Q30442532-2B5F62CF-93AC-4D86-84F5-5ABF90C1A808Q30499792-BFA7CCFC-9F4D-4AD8-AE2A-0698EB530A10Q30755598-F40E1C75-A7A8-4EBC-A36F-7C095B7D15A1Q30847206-774FCA93-2563-496D-94EC-AABBAC08D2CBQ31010610-2DE18AE1-0D48-48B9-83C3-28C4189D5138Q31986619-B76F34C4-B9AF-488C-A4D3-C1BC94A0D660Q33498649-747A122F-A807-40E9-998D-FC754DE3B0C1Q33539473-B615BFBB-E2FE-4C24-8A56-E8E64721C426Q33573813-D546F15D-02C5-4A6B-8CDC-81674AF35377Q33627654-6261BDC0-E0E0-47C4-B8BF-8286033BA4ACQ33699097-DFC8ACD1-8881-471C-B29A-FBEC4D2F59AD
P2860
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@en
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@nl
type
label
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@en
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@nl
prefLabel
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@en
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@nl
P2093
P1433
P1476
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.
@en
P2093
Jennette JC
Kluckman KD
Langenbach R
Smithies O
P304
P356
10.1016/0092-8674(95)90125-6
P407
P577
1995-11-01T00:00:00Z